Market Research Report

A quick peek into the report

Global Non-Oncology Precision Medicine Market

Focus on Application Area, Ecosystem Type, Country Data (15 Countries) - Analysis and Forecast, 2020-2030

Some Faq's

Frequently Asked Questions

Answer: The global non-oncology precision medicine market was estimated at $41.1 Billion in 2019 and is projected to grow at a CAGR of 11.03% during the forecast period, 2020-2030.

Answer: The impact of COVID-19 on non-oncology precision medicine market has been such that it has resulted in the unprecedented demand for non-oncology precision medicine along with affecting the supply chain of non-oncology precision medicine-based therapies.

Answer: The key development strategies that companies are opting for include product offerings, partnerships and alliances, regulatory and legal, mergers and acquisitions, and funding and investments. Among all these strategies partnerships and alliances as a strategy is the most preferred strategy.

Answer: Non-Oncology precision medicine can be used for infectious diseases, neurology, lifestyle and endocrinology, cardiovascular, gastroenterology, and others diseases.

Answer: There are several companies operating in the market. Some of the major organizations include Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., F. Hoffmann-La Roche AG, Danaher Corp., GlaxoSmithKline plc., Gilead Sciences, Inc. Illumina, Inc., Thermofisher Scientific, QIAGEN, and Quest Diagnostics.

Similar Product

You may also like

Global Precision Medicine Market
Published Year: 2020

Global Precision Medicine Market: Focus on Ecosystem, Technology, Application, Country Data (21 Coun

The global precision medicine market is set to witness a CAGR of 11.13% during the period...